159 related articles for article (PubMed ID: 15871766)
1. Benefits and drawbacks of the use of oral fluoropyrimidines as single-agent therapy in advanced colorectal cancer.
Cassidy J
Clin Colorectal Cancer; 2005 Apr; 5 Suppl 1():S47-50. PubMed ID: 15871766
[TBL] [Abstract][Full Text] [Related]
2. Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same.
Mayer RJ
J Clin Oncol; 2001 Nov; 19(21):4093-6. PubMed ID: 11689576
[No Abstract] [Full Text] [Related]
3. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.
Van Cutsem E; Twelves C; Cassidy J; Allman D; Bajetta E; Boyer M; Bugat R; Findlay M; Frings S; Jahn M; McKendrick J; Osterwalder B; Perez-Manga G; Rosso R; Rougier P; Schmiegel WH; Seitz JF; Thompson P; Vieitez JM; Weitzel C; Harper P;
J Clin Oncol; 2001 Nov; 19(21):4097-106. PubMed ID: 11689577
[TBL] [Abstract][Full Text] [Related]
4. Capecitabine: effective oral fluoropyrimidine chemotherapy.
McKendrick J; Coutsouvelis J
Expert Opin Pharmacother; 2005 Jun; 6(7):1231-9. PubMed ID: 15957975
[TBL] [Abstract][Full Text] [Related]
5. Capecitabine: an overview of the side effects and their management.
Saif MW; Katirtzoglou NA; Syrigos KN
Anticancer Drugs; 2008 Jun; 19(5):447-64. PubMed ID: 18418212
[TBL] [Abstract][Full Text] [Related]
6. [Oral fluoropyrimidines in the treatment of colorectal carcinoma].
Porschen R
Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S121-3. PubMed ID: 12817344
[No Abstract] [Full Text] [Related]
7. First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer.
Gambill BD
Clin Colorectal Cancer; 2001 May; 1(1):18-9. PubMed ID: 12445375
[No Abstract] [Full Text] [Related]
8. New options for outpatient chemotherapy--the role of oral fluoropyrimidines.
Cunningham D; Coleman R
Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541
[TBL] [Abstract][Full Text] [Related]
9. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
10. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.
Iqbal S; Lenz HJ
Expert Rev Anticancer Ther; 2004 Dec; 4(6):947-55. PubMed ID: 15606325
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine: fulfilling the promise of oral chemotherapy.
Hwang JJ; Marshall JL
Expert Opin Pharmacother; 2002 Jun; 3(6):733-43. PubMed ID: 12036413
[TBL] [Abstract][Full Text] [Related]
12. Capecitabine in the treatment of colorectal cancer.
O'Neill VJ; Cassidy J
Future Oncol; 2005 Apr; 1(2):183-90. PubMed ID: 16555988
[TBL] [Abstract][Full Text] [Related]
13. Practical considerations in the use of oral fluoropyrimidines.
Hoff PM
Semin Oncol; 2003 Jun; 30(3 Suppl 6):88-92. PubMed ID: 12802799
[TBL] [Abstract][Full Text] [Related]
14. Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation.
Ward S; Kaltenthaler E; Cowan J; Brewer N
Health Technol Assess; 2003; 7(32):1-93. PubMed ID: 14604497
[TBL] [Abstract][Full Text] [Related]
15. Capecitabine: indications and future perspectives in the treatment of metastatic colorectal and breast cancer.
Cassata A; Procoplo G; Alù M; Ferrari L; Ferrario E; Beretta E; Longarini R; Busto G; De Candis D; Bajetta E
Tumori; 2001; 87(6):364-71. PubMed ID: 11989587
[TBL] [Abstract][Full Text] [Related]
16. Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.
Lee JJ; Kim TM; Yu SJ; Kim DW; Joh YH; Oh DY; Kwon JH; Kim TY; Heo DS; Bang YJ; Kim NK
Jpn J Clin Oncol; 2004 Jul; 34(7):400-4. PubMed ID: 15342667
[TBL] [Abstract][Full Text] [Related]
17. Single-agent capecitabine: a reference treatment for taxane-pretreated metastatic breast cancer?
Seidman AD; O'Shaughnessy J; Misset JL
Oncologist; 2002; 7 Suppl 6():20-8. PubMed ID: 12454316
[TBL] [Abstract][Full Text] [Related]
18. Capecitabine versus continuous-infusion 5-fluorouracil for colorectal cancer: a retrospective efficacy and safety comparison.
Saif MW
Clin Colorectal Cancer; 2005 Jul; 5(2):89-100. PubMed ID: 16098249
[TBL] [Abstract][Full Text] [Related]
19. Update on capecitabine alone and in combination regimens in colorectal cancer patients.
Silvestris N; Maiello E; De Vita F; Cinieri S; Santini D; Russo A; Tommasi S; Azzariti A; Numico G; Pisconti S; Petriella D; Lorusso V; Millaku A; Colucci G
Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S46-55. PubMed ID: 21129610
[TBL] [Abstract][Full Text] [Related]
20. The role of capecitabine in the treatment of colorectal cancer in the elderly.
Pasetto LM; Monfardini S
Anticancer Res; 2006; 26(3B):2381-6. PubMed ID: 16821620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
